Skip to content

Study · Not a test of the peptide alone · 2020

1 result

Nebulized Mesenchymal Stem Cell Derived Conditioned Medium Retains Antibacterial Properties Against Clinical Pathogen Isolates.

McCarthy SD, Horgan E, Ali A, Masterson C, Laffey JG, MacLoughlin R, O'Toole D

Journal of aerosol medicine and pulmonary drug delivery15 Nov 2019Cited by 42 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, LL-37 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking LL-37.

  1. 01LabNot a test of LL-37 aloneIn vitro (cell-free)Other

    In MSC conditioned medium, LL‑37 protein did not appear to survive vibrating mesh nebulization, while other secreted antimicrobial peptides and IL-8 were largely intact.

    In plain wordsIn lab tests, LL‑37 in stem cell culture fluid did not seem to survive nebulization.

    Peptide
    LL-37
    Outcome
    DecreaseLL-37 protein survival after nebulization
    Study

    n: not reported in source

    MSC conditioned medium passed through a vibrating mesh nebulizer
    Outcome group
    Pharmacokinetics · Pharmacology

    Source sentences

    Summary
    Interestingly, LL-37 protein did not appear to survive nebulization
    1 context sentence
    Summary · context
    MSC-CM from bone marrow (BM) and umbilical cord (UC) MSCs were passed through the commercially available Aerogen Solo nebulizer.

    In this study, LL-37 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking LL-37.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    11 Oct 2026, 00:50 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 02:57 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.